Bioprinted Nanoparticles and Methods of Use

• US 20110177590A1
• Filed: 12/13/2010
• Published: 07/21/2011
• Est. Priority Date: 12/11/2009
• Status: Abandoned Application

• Current Assignee: Drexel University
• Original Assignee: Drexel University
• Inventors: Buyukhatipoglu, Kivilcim, Clyne, Alisa Morss, Sun, Wei, Chang, Robert
• Application Number:
  US12/966,645
• Publication Number:
  US 20110177590A1
• Time in Patent Office: Days
• US Class Current: 435/325
• CPC Class Codes: A61L 2300/80 characterised by a special chemical form
• CPC Class Codes: A61L 27/38 containing added animal cells organs or tissue containing native cells A61L27/36
• CPC Class Codes: A61L 27/44 having a macromolecular matrix
• CPC Class Codes: A61L 27/50 Materials characterised by their function or physical properties , e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
• CPC Class Codes: A61L 27/54 Biologically active materials, e.g. therapeutic substances A61L27/227 takes precedence
• CPC Class Codes: B82Y 25/00 Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
• CPC Class Codes: C12N 2533/74 Alginate
• CPC Class Codes: C12N 5/0006 Modification of the membrane of cells, e.g. cell decoration
• CPC Class Codes: C12N 5/0068 General culture methods using substrates for specific animal cell type C12N5/06
• CPC Class Codes: H01F 1/0045 Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use preparation of fullerenes in general C01B32/15
• CPC Class Codes: H01F 1/0054 Coated nanoparticles, e.g. nanoparticles coated with organic surfactant

Abstract

The present invention provides compositions and methods that combine the initial patterning capabilities of a direct cell printing system with the active patterning capabilities of magnetically labeled cells, such as cells labeled with superparamagnetic nanoparticles. The present invention allows for the biofabrication of a complex three-dimensional tissue scaffold comprising bioactive factors and magnetically labeled cells, which can be further manipulated after initial patterning, as well as monitored over time, and repositioned as desired, within the tissue engineering construct.

Claims

1. A process for manufacturing complex structure comprising:

designing a printable structure via a computer-operable software application;

converting the designed structure into a heterogeneous material and multi-part assembly model; and

printing the designed structure using a device comprising a plurality of differentiated, specialized nozzles, wherein at least one of the nozzles is specialized for the deposition of at least one material comprising a magnetic particle.

2. The process of claim 1, wherein the structure is a tissue scaffold.

3. The process of claim 1, wherein the material comprises a cell.

4. The process of claim 1, wherein the material comprises a magnetically labeled bioactive factor.

5. The process of claim 4, further comprising repositioning the magnetically labeled bioactive factor on or within the structure after initial deposit via a magnetic field after printing the magnetically labeled bioactive factor.

6. The process of claim 1, further comprising repositioning the material comprising a magnetic particle via a magnetic field after printing at least the at least one material comprising a magnetic particle.

7. The process of claim 1, wherein the magnetic particle is a superparamagnetic nanoparticle.

8. The process of claim 7, wherein the superparamagnetic nanoparticle has a diameter between about 5-30 nm.

9. The process of claim 7, wherein the superparamagnetic nanoparticle comprises iron oxide.

10. The process of claim 1, further comprising using Boolean, scaling, smoothing, or mirroring to modify the design prior to conversion into a heterogeneous material and multi-part assembly model.

11. The process of claim 1, wherein the designing further comprises incorporating data taken from MRI, CT or other patient specific data into the designed structure.

12. The process of claim 1, wherein the designing further comprises incorporating a biomimetic and non-biomimetic feature into the designed structure.

13. The process of claim 2, wherein printing the material comprising a magnetic particle comprises depositing magnetically labeled cells or magnetically labeled biological factors.

14. The process of claim 13, further comprising improving histological accuracy, cell ratios, and spatial patterning of cells in the printed structure.

15. The process of claim 1, wherein the structure comprises an artificial organ, an artificial vasculature or channel system, or a sample for cytotoxicity testing.

16. The process of claim 1, wherein the structure comprises a biochip, biosensor, bionic, cybernetic, mechanoactive, or a bioactive tissue scaffold.

17. The process of claim 1, wherein the structure is used in drug delivery.

18. A multi-nozzle biopolymer deposition apparatus comprising:

a data processing system which processes a designed scaffold model and converts it into a layered process tool path;

a motion control system driven by the layered process tool path; and

a material delivery system comprising a plurality of differentiated, specialized nozzles for simultaneously depositing a plurality of biopolymers having different viscosities, thereby constructing a scaffold from the designed scaffold model, wherein at least one of the nozzles deposits at least one magnetically labeled material,

19. The apparatus of claim 18, wherein the at least one magnetically labeled material is a magnetically labeled bioactive factor.

20. The apparatus of claim 18, wherein the at least one magnetically labeled material is a cell.

21. The apparatus of claim 18, wherein the data processing system utilizes Boolean, scaling, smoothing, or mirroring to modify the designed scaffold model.

22. The apparatus of claim 18, wherein the data processing system incorporates data taken from MRI, CT or other patient specific data into the designed scaffold model.

23. The apparatus of claim 18, wherein the data processing system incorporates a biomimetic and non-biomimetic feature into the designed scaffold model.

24. The apparatus of claim 18, wherein the scaffold comprises an artificial organ, an artificial vasculature or channel system, or a sample for cytotoxicity testing.

25. A system for generating a biocompatible structure comprising:

designing a printable structure via a computer-operable software application;

converting the designed structure into a heterogeneous material and multi-part assembly model;

printing the designed structure using a device comprising a plurality of differentiated, specialized nozzles, wherein at least one of the nozzles is specialized for the deposition of at least one material comprising a magnetic particle; and

applying a magnetic field to reposition the at least one material comprising the magnetic particle after its deposition.

26. The system of claim 25, wherein the at least one material comprising the magnetic particle is repositioned prior to completion of all materials being deposited.

27. The system of claim 25, wherein the at least one material comprising the magnetic particle is repositioned after all materials have been deposited.